As the cannabis industry navigates a complex regulatory landscape in April 2026, this week’s news cycle is dominated by a high-stakes standoff in Texas and significant data-driven shifts in consumer preferences. While the federal government remains silent on long-awaited rescheduling efforts, states are taking matters into their own hands, creating a fragmented but rapidly evolving market environment.
Week in Weed: Key Highlights
- Texas Hemp Injunction: A Travis County judge has temporarily blocked new, aggressive licensing fees from the Texas Department of State Health Services (DSHS), providing a lifeline to businesses facing potential insolvency.
- Pre-Roll Market Dominance: The 2026 ‘State of the Pre-Roll’ report from Custom Cones USA reveals pre-rolls have overtaken flower as the top-selling category by unit volume, hitting $3.6 billion in revenue.
- Rescheduling Limbo: Frustration mounts as Representative Steve Cohen (D-TN) demands an update from the DOJ on the stalled marijuana rescheduling timeline.
- Legislative Progress: Maryland continues its progressive streak, with Governor Wes Moore signing a bill protecting veterinarians who recommend medical cannabis for pets, marking a cultural and legal shift in animal care.
The Texas Regulatory Standoff: A Market on the Brink
The most volatile story in the cannabis sector this week is the legal battle over hemp-derived THC products in Texas. For an estimated $8 billion industry, the stakes could not be higher. Following the Texas Legislature’s failure to pass an outright ban on hemp-derived THC during the previous session, Governor Greg Abbott directed state agencies to implement strict regulatory measures.
The DSHS Fee Proposal
The Texas Department of State Health Services (DSHS) initially proposed exorbitant licensing fees for manufacturers and retailers of hemp-derived products. These fees, which industry advocates described as a ‘death sentence’ for small businesses, reached as high as $25,000 for manufacturers. After significant outcry and pushback from trade associations, the agency reduced these figures to $10,000 and $5,000, respectively—still a massive jump from the previous $250 and $150 rates.
Judicial Intervention
The industry, represented by attorneys like Andrea Steel, moved quickly to file lawsuits, arguing that these fees were unconstitutional and exceeded the agency’s regulatory authority. On April 10, a Travis County judge granted a temporary restraining order (TRO), halting the implementation of these rules. The conflict has essentially frozen the market, with business owners on ‘pins and needles’ awaiting the next hearing on April 23. This standoff reflects a broader trend in the US: state-level agencies are attempting to impose ‘de facto’ prohibitions through administrative rulemaking when legislative efforts fail.
The New Center of Gravity: The Rise of Pre-Rolls
Away from the courtroom drama, the industry is witnessing a decisive consumer pivot. According to the 2026 Custom Cones USA market report, pre-rolls have officially become the most-sold product category in the United States by unit volume, ending the long-standing dominance of loose-leaf flower.
Drivers of Growth
Several factors are fueling this trend. First, there is a marked consumer preference for convenience and consistent dosage. Second, the rise of ‘infused’ pre-roll products—incorporating distillates, kief, and live resin—has injected new life and higher price points into the segment.
Economic Impact
With the category generating $3.6 billion in 2025 and 383 million units sold, the implications for retailers are clear: inventory strategies must shift. Multi-pack formats, particularly 2.5-gram five-packs, are outperforming single units. This ‘speed and scale’ era of cannabis consumption suggests that the future of the market lies in value-added, ready-to-consume products rather than traditional raw commodity sales.
Federal Impasse and State-Level Innovation
While Texas fights over hemp, the federal landscape remains static. Despite widespread optimism in late 2025 regarding potential rescheduling, the DOJ has provided no concrete timeline. This delay is forcing states to act as their own regulatory laboratories.
Cultural Shifts: Maryland’s Animal Care Bill
Maryland’s recent legislation, signed by Governor Wes Moore, is a prime example of states moving faster than the federal government. By providing legal safe harbor to veterinarians who recommend cannabis for pets suffering from chronic pain or cancer, Maryland is acknowledging the normalization of cannabis in home care. This bill is not just about pets; it is a signal that the stigma surrounding cannabis use for therapeutic purposes is rapidly eroding.
The Future of Cannabis Policy
As we look ahead, the interplay between state enforcement and federal inaction will continue to create market friction. Whether it is the ‘One Big Beautiful Bill Act’ narrowing the definition of hemp or individual state courts blocking administrative overreach, the industry is entering a maturation phase where compliance, litigation, and consumer demand are moving at conflicting speeds. Industry players must prepare for a 2027 where the ‘Wild West’ era of unregulated hemp and cannabis markets is officially replaced by a complex, highly regulated, and state-centric framework.
FAQ: People Also Ask
Q: Why is the Texas hemp industry currently in legal trouble?
A: The Texas hemp industry is facing a regulatory challenge regarding new, high-cost licensing fees proposed by the Texas Department of State Health Services (DSHS). A temporary restraining order has been issued by a Travis County judge, pausing these fees until at least April 23, 2026, as the courts determine if the rules exceed the state’s authority.
Q: What does the shift toward pre-rolls mean for cannabis brands?
A: The shift indicates that consumers are prioritizing convenience and product innovation. For brands, this means shifting focus from bulk flower sales to high-margin, value-added products like infused pre-rolls and multi-pack bundles, which currently drive the most significant growth in the sector.
Q: Is federal rescheduling of cannabis still expected in 2026?
A: While there was high anticipation in late 2025, rescheduling has not materialized as of mid-April 2026. Members of Congress, including Representative Steve Cohen, have requested updates from the DOJ and DEA, but no timeline has been confirmed, leaving the industry in a state of regulatory uncertainty.
Q: What is the significance of the Maryland legislation regarding pets?
A: Maryland’s new law provides legal protections for veterinarians to recommend medical cannabis for animals. This marks a milestone in cannabis policy, moving it into the sphere of standard veterinary medicine and signaling a broader cultural acceptance of cannabis-based therapeutics for non-human patients.
